G-tyčinky-CRE

Bližší informace k tomuto tématu najdete v knize Antibiotická politika a prevence infekcí v nemocnici (podrobnosti zde) autorů Jindrák V., Hedlová D., Urbášková P. a kol., v kapitole Specifické postupy u vybraných skupin rezistentních bakterií na straně 659.

Související guidelines:

• Management of Multidrug-Resistant Organisms In Healthcare Settings (CDC, 2006)
• Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients (ECDC, 2014)
• Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) throuhg patient tranfer between healthcare facilities, with special emphasis on cross-border transfer (ECDC, 2011)
• Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities - MMWR, March 20, 2009, str. 256-259 (CDC, 2009)
• Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) (CDC, 2012)
• Carbapenem-resistant Entrobacteriaceae (CRE) Control and Prevetnion Toolkit (AHRQ, 2014)